Key facts
- Notable investors include Pioneer Fund, Soma Capital, Gradient Ventures, Tau Ventures, Davidovs Venture Collective — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Kerna Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for Kerna Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kerna Labs
Developer of machine learning models designed to create genetic medicines. The company utilizes foundation models of Ribonucleic acid to identify and optimize sequences with enhanced protein output, while preventing off-target expression, providing the healthcare industry with precision-targeted delivery for cell-specific therapeutic effects.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2024
- Employees
- 8
- Website
- kernalabs.ai/
- Ownership
- Privately Held (backing)
Kerna Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kerna Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kerna Labs in its N-PORT filings yet. We sweep new filings monthly.